openPR Logo
Press release

Sardina Systems secures €1.6M Series A funding, led by Deepbridge Capital

09-07-2021 02:46 PM CET | IT, New Media & Software

Press release from: Sardina Systems

Sardina Systems secures investment

Sardina Systems secures investment

Financial support from Deepbridge Capital will speed up the development of innovative technologies in cloud computing and help the company expand to new markets.
Sardina Systems, an award-winning, leading European cloud software company, FishOS developer and distributor, today, 10 August 2021, announced the successful completion of a Series A funding round led by Deepbridge Capital, a UK-based fund manager, via the Deepbridge Technology Growth EIS fund. The company has secured €1.2M of the investment. The total amount for the Series A investment is scheduled to reach €1.6M. This financing will accelerate the company’s expansion to global markets of enterprise cloud management software, through intensive product development and the building of an extensive network of channel partners.

Sardina Systems’s FishOS solution is described as the world’s first Zero-Downtime Upgrader for OpenStack and Kubernetes clouds, allowing enterprises to easily access highly scalable and secure cloud environments.

Deepbridge supports investee companies through their proven experience of building growth businesses, involving a network of investors, technology advisors, and industry partners. Matthias Mueller, a Senior Technical Adviser at Deepbridge, is appointed as a new Non-Executive Director representing Deepbridge Capital on the Sardina Systems’ Board. Matthias Mueller has more than 30 years of experience in the IT and Systems Integration sector and vast experience in innovation-led technology engineering.

Kenneth Tan, Executive Director and a founder of Sardina Systems, said:
“Being at the stage of a sharp leap of development, Sardina Systems needs additional resources to support its growth and bring benefits to FishOS customers. Thanks to the financial partnership with Deepbridge Capital, we plan to ramp up product development, enhance FishOS with the latest cutting-edge technologies and enlarge our, rapidly growing channel partner network – providing developers and organizations with access to, amongst other integrated operations tools in FishOS, multi-award-winning AI-powered Health Management and Workload Management, and the world’s first Zero-Downtime Upgrader for OpenStack and Kubernetes clouds.
I am delighted to welcome such a highly experienced expert as Matthias to Sardina’s Board of Directors. His appointment enriches Sardina’s experience and helps the company move forward focusing on its strategic business goals and customers’ success. We are excited about this next stage of Sardina’s growth.”

Matthias Mueller, Non-Executive Director at Sardina Systems representing Deepbridge, added:
“I am delighted to be joining the board of Sardina Systems at this critical stage in their growth journey. At Deepbridge, we are constantly looking for innovative growth-focused companies who have the potential to expand their product(s) into multiple markets, on a global scale. Sardina Systems, with its highly experienced founding team, is a great example of this and I look forward to working with them to help develop the business over the coming years. Sardina Systems is exactly the type of business the UK Government’s Enterprise Investment Scheme is designed to support, being a growth-focused unique technology with global reach.”

Sardina Systems, 7 Bell Yard, London UK

About Sardina Systems

Sardina Systems is a leading European operation management software developer and vendor headquartered in the United Kingdom, with a local presence in Germany, Luxembourg, Ukraine, and Russia. FishOS, the brainchild of Sardina Systems, is a private cloud management software platform enabling enterprises to rapidly experience the value of scalable, agile, and flexible OpenStack and Kubernetes clouds while maximizing the utility of their resources with zero-downtime operations.
Sardina Systems delivers a full suite of operations management tools and professional services and support that allows its customers to overcome the challenges of large-scale data center operations.
Since 2014, Sardina Systems has significantly expanded its business geography due to the extensive development of the channel partner network. In 2015, FishOS won the IDC HPC Innovation Award. In 2017, Sardina Systems was announced as the best Open Data Center Project and won a DCD Award with FishOS.
For more information, visit

About Deepbridge Capital

Deepbridge Capital aims to redefine the growth capital market by providing private investors with access to opportunities that are sourced, reviewed and managed by its team of sector specialists. Supporting energetic, passionate and knowledgeable management teams, Deepbridge seeks to identify highly innovative companies to grow into highly successful companies, intending to provide optimal returns to investors. As investment specialists in the technology, life sciences and renewable energy sectors, Deepbridge works with investee companies throughout their funding journey with an eye always on producing a suitable exit for investors.
For more information, visit

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Sardina Systems secures €1.6M Series A funding, led by Deepbridge Capital here

News-ID: 2383935 • Views: 210

More Releases from Sardina Systems

Sardina Systems, a leading European developer and vendor of cloud management software, is pleased to announce the appointment today of John Higgins CBE as its non-executive Chairman. John Higgins was the Director-General of DigitalEurope, the tech industry association in Brussels whose members included major tech companies such as Dell, Google, HP, IBM and Microsoft. Today John is President of the BCS, the UK’s Chartered Institute for IT, the professional body for
Sardina Systems announces it has joined the Global Equinix Partner Program
London, UK, June 9, 2021 -- Sardina Systems, a leading OpenStack and Kubernetes platforms vendor addressing the full lifecycle of clouds with pre-integrated operations tools, today announced it had joined the Equinix Partner Program to expand its hosted private cloud solution to enterprises across the globe. By becoming a Global Partner of Equinix – the world’s digital infrastructure company – Sardina Systems provides customers with a global reach advantage,
A Scale-out Enterprise Kubernetes Software-Defined Storage Solution by Sardina S …
Sardina Systems, a leading OpenStack and Kubernetes platforms software vendor addressing the full lifecycle of clouds with pre-integrated operations tools, and Ambedded Technology, a software-defined storage company with expertise on Ceph storage and embedded arm platform, today announced they have partnered to deliver a highly efficient and modern Software Defined-Storage solution. Companies looking for an agile, automated SDS Kubernetes based solution to replace the static and inefficient hardware can now
Sardina Systems offers free cloud migration to FishOS OpenStack & Kubernetes to …
London, UK - January 25, 2021 - Sardina Systems has announced free cloud migration to FishOS OpenStack and Kubernetes to all enterprise customers facing vScaler personnel exodus and want to continue to benefit from the on-premise private cloud with zero downtime operations. With more businesses moving applications and data to the cloud, service disruption or downtime can be devastating. With its FishOS HCI cloud technology, Sardina Systems is ready to

All 5 Releases

More Releases for Deepbridge

Various Targets for the Disease Treatment Drives the Growth of Uveitis Therapeut …
The study analyzed that the uveitis therapeutics pipeline comprises 33 drug candidates, of which five drug candidates are in Phase III stage of development, seven drug candidates are in Phase II stage, three drug candidates are in Phase I, 15 drug candidates are in Pre-Clinical stage and three drug candidates are in Discovery stage. Uveitis is a type of inflammatory disease that causes swelling and destroys eye tissues. Occurrence of